Compounds > n-methyl-3,4-methylenedioxyamphetamine

n-methyl-3,4-methylenedioxyamphetamine and kynurenine

n-methyl-3,4-methylenedioxyamphetamine has been researched along with kynurenine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abuin-Martínez, C; Colado, MI; Giménez-Gómez, P; Gutiérrez-López, MD; Morales-Puerto, N; O'Shea, E; Pérez-Hernández, M; Vidal, R	1

Other Studies

1 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and kynurenine

Article	Year
Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor. Neuropharmacology, 2021, 04-01, Volume: 187 Topics: Animals; Autoradiography; Hippocampus; Kynurenine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Rats; Receptors, Aryl Hydrocarbon; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Tryptophan Oxygenase	2021

Article

Year

Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor.

Neuropharmacology, 2021, 04-01, Volume: 187

Topics: Animals; Autoradiography; Hippocampus; Kynurenine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Rats; Receptors, Aryl Hydrocarbon; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Tryptophan Oxygenase

2021